Jun 2026 (Q2 FY26) — Aug 6, 2026
Blend Labs Q2 FY26 — Autopilot Commercialization and Internal AI Transformation Drive Optimism Amidst Macro Headwinds
Read the full callBlend Labs earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 33.8 | +7.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -4.7 | +10.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -1.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $3.34 on 14 Oct 2025 → $1. High $3.56 (24 Oct 2025), low $0.92 (14 Oct 2026).
Overview
Call summaries
Blend Labs Q2 FY26 — Autopilot Commercialization and Internal AI Transformation Drive Optimism Amidst Macro Headwinds
Read the full callEvery analysed call
Financials
Net profit, year on year: +78% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 33 | 41 | 27 | 32 | 33 | 32 | 31 | 34 |
| Operating profit | -11 | -2 | -8 | -5 | -5 | -5 | -5 | -2 |
| Operating margin | −34.1% | −4.3% | −29.7% | −15.3% | −16.4% | −15.3% | −16.4% | −4.7% |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Profit before tax | -1 | -1 | -7 | -4 | 12 | -4 | -5 | -1 |
| Tax rate | −3.4% | −3.8% | −0.4% | −1.1% | 0.2% | −1.1% | −1.3% | −8.8% |
| Net profit | -2 | -1 | -10 | -7 | 12 | -7 | -8 | -1 |
| EPS ($ per share) | -0.03 | — | -0.06 | -0.04 | 0.02 | — | -0.05 | -0.03 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -273 | -443 | -1,163 | -1,342 | -1,385 | -1,392 |
| Total liabilities | — | 52 | 302 | 269 | 179 | 40 | 41 |
| Fixed assets | — | 5 | 6 | 6 | 4 | 12 | 23 |
| Investments | — | — | 334 | 230 | 106 | 56 | 25 |
| Total assets | — | 216 | 1,112 | 433 | 206 | 178 | 170 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -59 | -65 | -128 | -190 | -128 | -13 | 12 |
| Cash from investing | -66 | -8 | -634 | 99 | 127 | 45 | 19 |
| Cash from financing | 133 | 91 | 934 | 2 | -91 | -21 | -33 |
| Net cash flow | 8 | 18 | 172 | -89 | -91 | 11 | -3 |
| Capital expenditure | -1 | -1 | -2 | -2 | -0 | -10 | -12 |
| Free cash flow | -60 | -66 | -129 | -192 | -128 | -23 | -0 |
107 filings between Oct 20, 2025 and Oct 12, 2026.
Purchases
$33.70M
34 purchases by 1 insider
Sales
$559.0K
15 sales by 6 insiders
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 1 other.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Haveli Investments, L.P. | $33.70M | — | Aug 17, 2026 |
| Kneafsey Brian | — | $227.6K | Jan 15, 2026 |
| Ghamsari Nima | — | $124.2K | Oct 12, 2026 |
| Venkatramani Srinivasan | — | $106.8K | Sep 11, 2026 |
| Tkach Oxana | — | $56.2K | Aug 17, 2026 |
| Thomson Matthew Christopher | — | $30.1K | Aug 5, 2026 |
| Ling Winnie | — | $14.0K | Oct 20, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Ghamsari Nima HEAD OF BLEND | Sale 10b5-1 plan | 25,098 | $24.5K |
| Oct 5, 2026 | Ghamsari Nima HEAD OF BLEND | Sale 10b5-1 plan | 24,272 | $24.7K |
| Sep 28, 2026 | Ghamsari Nima HEAD OF BLEND | Sale 10b5-1 plan | 22,523 | $24.8K |
| Sep 21, 2026 | Ghamsari Nima HEAD OF BLEND | Sale 10b5-1 plan | 21,009 | $25.0K |
| Sep 14, 2026 | Ghamsari Nima HEAD OF BLEND | Sale 10b5-1 plan | 17,731 | $25.3K |
| Sep 11, 2026 | Venkatramani Srinivasan Head of Product Tech & Cust Op | Sale 10b5-1 plan | 74,705 | $106.8K |
| Aug 20, 2026 | Venkatramani Srinivasan Head of Product Tech & Cust Op | Tax withheld | 29,372 | $44.1K |
| Aug 20, 2026 | Ghamsari Nima HEAD OF BLEND | Option exercise | 125,000 | — |
| Aug 20, 2026 | Thomson Matthew Christopher Head of Revenue | Tax withheld | 24,350 | $36.5K |
| Aug 20, 2026 | Ghamsari Nima HEAD OF BLEND | Tax withheld | 241,701 | $362.6K |
| Aug 20, 2026 | Ghamsari Nima HEAD OF BLEND | Option exercise | 114,229 | — |
| Aug 20, 2026 | Venkatramani Srinivasan Head of Product Tech & Cust Op | Option exercise | 81,250 | — |
| Aug 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Option exercise | 31,250 | — |
| Aug 20, 2026 | Thomson Matthew Christopher Head of Revenue | Option exercise | 100,000 | — |
| Aug 20, 2026 | Ghamsari Nima HEAD OF BLEND | Option exercise | 375,000 | — |
| Aug 20, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Option exercise | 12,500 | — |
| Aug 20, 2026 | Ream Jason Head of Finance and Admin. | Option exercise | 550,000 | — |
| Aug 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Tax withheld | 25,385 | $38.1K |
| Aug 20, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Option exercise | 25,000 | — |
| Aug 20, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Tax withheld | 10,667 | $16.0K |
| Aug 20, 2026 | Ream Jason Head of Finance and Admin. | Tax withheld | 133,926 | $200.9K |
| Aug 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Option exercise | 39,164 | — |
| Aug 17, 2026 | Haveli Investments, L.P. Director | Purchase | 17,397 | $25.1K |
| Aug 17, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Sale 10b5-1 plan | 21,209 | $30.7K |
| Aug 5, 2026 | Thomson Matthew Christopher Head of Revenue | Sale 10b5-1 plan | 15,041 | $30.1K |
| Jun 15, 2026 | Haveli Investments, L.P. Director | Purchase | 650,000 | $1.12M |
| Jun 12, 2026 | Haveli Investments, L.P. Director | Purchase | 256,928 | $436.2K |
| Jun 11, 2026 | Haveli Investments, L.P. Director | Purchase | 250,000 | $435.1K |
| Jun 11, 2026 | Sullivan Bryan Edmund Director | Option exercise | 50,000 | — |
| Jun 11, 2026 | Woersching Eric H. Director | Option exercise | 50,000 | — |
| Jun 11, 2026 | Chen Gerald C. Director | Option exercise | 50,000 | — |
| Jun 11, 2026 | Lantz Erin N Director | Option exercise | 50,000 | — |
| Jun 11, 2026 | Mayopoulos Timothy J Director | Option exercise | 50,000 | — |
| Jun 10, 2026 | Haveli Investments, L.P. Director | Purchase | 723,460 | $1.21M |
| Jun 9, 2026 | Haveli Investments, L.P. Director | Purchase | 178,677 | $303.9K |
| Jun 8, 2026 | Haveli Investments, L.P. Director | Purchase | 216,798 | $368.2K |
| Jun 5, 2026 | Haveli Investments, L.P. Director | Purchase | 28,299 | $45.3K |
| Jun 3, 2026 | Haveli Investments, L.P. Director | Purchase | 240,307 | $376.1K |
| May 27, 2026 | Haveli Investments, L.P. Director | Purchase | 1,600 | $2.4K |
| May 26, 2026 | Haveli Investments, L.P. Director | Purchase | 243,805 | $355.7K |
| May 22, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Sale 10b5-1 plan | 5,625 | $8.8K |
| May 22, 2026 | Haveli Investments, L.P. Director | Purchase | 798,223 | $1.18M |
| May 21, 2026 | Haveli Investments, L.P. Director | Purchase | 8,117 | $12.2K |
| May 20, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Option exercise | 12,500 | — |
| May 20, 2026 | Tkach Oxana PRINCIPAL ACCOUNTING OFFICER | Option exercise | 25,000 | — |
| May 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Tax withheld | 25,385 | $37.6K |
| May 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Option exercise | 39,164 | — |
| May 20, 2026 | Ling Winnie HEAD OF LEGAL AND PEOPLE | Option exercise | 31,250 | — |
| May 20, 2026 | Ghamsari Nima HEAD OF BLEND | Tax withheld | 241,701 | $357.7K |
| May 20, 2026 | Ghamsari Nima HEAD OF BLEND | Option exercise | 114,229 | — |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Blend Labs, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading